The anticoagulants rivaroxaban and low molecular weight heparin prevent PICC-related upper extremity venous thrombosis in cancer patients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference32 articles.
1. Advantages and disadvantages of peripherally inserted central venous catheters (PICC) compared to other central venous lines: a systematic review of the literature;Johansson;Acta Oncol,2013
2. The risk of ven-ous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients;Jones;Thromb J,2017
3. Peripherally inserted central catheter-related vein thrombosis in patients with lung cancer;Kang;Clin Appl Thromb Hemost,2017
4. Central venous device-related thrombosis as imaged with MDCT in oncologic patients: prevalence and findings;Catalano;Acta Radiol,2011
5. Safety and effectiveness of central venous catheterization in patients with cancer: prospective observational study;Kim;J Korean Med Sci,2010
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The impact of internet multidisciplinary continuity care on the living quality of home-based patients with malignant tumors undergoing PICC catheterization;American Journal of Translational Research;2024
2. Efficacy and Safety of Rivaroxaban Versus Enoxaparin in Prevention of Recurrence of Venous Thrombo-Embolism Events in Cancer Patients: A Meta-Analysis;Clinical and Applied Thrombosis/Hemostasis;2024-01
3. Risk Factors and Predictive Models for Peripherally Inserted Central Catheter Unplanned Extubation in Patients With Cancer: Prospective, Machine Learning Study;Journal of Medical Internet Research;2023-11-16
4. Comparison of the Efficacy and Safety of Rivaroxaban and Low Molecular Heparin in Preventing Venous Thromboembolism in Inpatient Cancer Patients;Annals of Pharmacotherapy;2023-06-13
5. Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review;Cancers;2023-05-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3